Extract from the Register of European Patents

EP About this file: EP4100072

EP4100072 - INJECTABLE IN VIVO CROSSLINKING MATERIALS FOR USE AS SOFT TISSUE FILLERS [Right-click to bookmark this link]
StatusGrant of patent is intended
Status updated on  01.02.2026
Database last updated on 09.04.2026
FormerExamination is in progress
Status updated on  03.10.2024
FormerRequest for examination was made
Status updated on  11.11.2022
FormerThe international publication has been made
Status updated on  13.08.2021
Formerunknown
Status updated on  10.03.2021
Most recent event   Tooltip20.02.2026New entry: Renewal fee paid 
Applicant(s)For all designated states
Boston Scientific Scimed Inc.
One Scimed Place
Maple Grove, Minnesota 55311 / US
[2022/50]
Inventor(s)01 / DELANEY, JR., Joseph T.
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
02 / BODEN, Mark W.
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
03 / MURPHY, John
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
04 / MOLNAR, Viktoria
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
05 / DYNDIKOVA, Tatyana
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
06 / ZIPP, Allison
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
07 / KOLSTE, Kolbein K.
c/o Boston Scientific Scimed, Inc. One Scimed
Place
Maple Grove, Minnesota 55311 / US
 [2022/50]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2022/50]
Application number, filing date21709178.402.02.2021
[2022/50]
WO2021US16213
Priority number, dateUS202062969863P04.02.2020         Original published format: US 202062969863 P
[2022/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021158546
Date:12.08.2021
Language:EN
[2021/32]
Type: A1 Application with search report 
No.:EP4100072
Date:14.12.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 12.08.2021 takes the place of the publication of the European patent application.
[2022/50]
Search report(s)International search report - published on:EP12.08.2021
ClassificationIPC:A61L27/18
[2022/50]
CPC:
A61L27/18 (EP,US); A61L27/16 (US); A61L27/3839 (US);
A61L27/50 (US); A61L2400/06 (EP); A61L2430/34 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/50]
TitleGerman:INJIZIERBARE IN VIVO VERNETZENDE MATERIALIEN ZUR VERWENDUNG ALS WEICHGEWEBE-FÜLLSTOFFE[2022/50]
English:INJECTABLE IN VIVO CROSSLINKING MATERIALS FOR USE AS SOFT TISSUE FILLERS[2022/50]
French:MATÉRIAUX DE RÉTICULATION IN VIVO INJECTABLES DESTINÉS À ÊTRE UTILISÉS EN TANT QUE CHARGES DE TISSUS MOUS[2022/50]
Entry into regional phase29.08.2022National basic fee paid 
29.08.2022Designation fee(s) paid 
29.08.2022Examination fee paid 
Examination procedure29.08.2022Examination requested  [2022/50]
29.08.2022Date on which the examining division has become responsible
02.03.2023Amendment by applicant (claims and/or description)
04.10.2024Despatch of a communication from the examining division (Time limit: M04)
03.02.2025Reply to a communication from the examining division
02.02.2026Communication of intention to grant the patent
Fees paidRenewal fee
22.02.2023Renewal fee patent year 03
20.02.2024Renewal fee patent year 04
18.02.2025Renewal fee patent year 05
19.02.2026Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X] EP2389925  (TYCO HEALTHCARE et al.) [X] 1-15 * page 2, paragraphs 0006, 0007 * * page 4, paragraph 0044 * * page 6, paragraph 0063 * * page 9, paragraph 0096 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.